Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 16, 2022
Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer
Kjersti Skipar, Tord Hompland, Kjersti Vassmo Lund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2016
Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer
Christina S Fjeldbo, Cathinka H Julin, Malin Lando, et al.
British Journal of Cancer
|
March 25, 2022
A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients
Unn Beate Salberg, Vilde Eide Skingen, Christina Sæten Fjeldbo, et al.
Cancer Research
|
June 28, 2018
Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients
Tord Hompland, Knut Håkon Hole, Harald Bull Ragnum, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 27, 2024
A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study
Joseph Marsilla, Jessica Weiss, Xiang Y Ye, et al.
Epigenetics
|
August 21, 2015
Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer
Malin Lando, Christina S Fjeldbo, Saskia M Wilting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2024
An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer
Jelena Lukovic, Melania Pintilie, Kathy Han, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 17, 2013
Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer
Harald Bull Ragnum, Kathrine Røe, Ruth Holm, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 10, 2018
Low dose-rate irradiation with [<sup>3</sup>H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft model
Stine Gyland Mikalsen, Lars Tore Gyland Mikalsen, Joe Alexander Sandvik, et al.
Molecular Oncology
|
January 22, 2022
miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer
Anja Nilsen, Tiril Hillestad, Vilde E Skingen, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 16, 2022
Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer
Kjersti Skipar, Tord Hompland, Kjersti Vassmo Lund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2016
Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer
Christina S Fjeldbo, Cathinka H Julin, Malin Lando, et al.
British Journal of Cancer
|
March 25, 2022
A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients
Unn Beate Salberg, Vilde Eide Skingen, Christina Sæten Fjeldbo, et al.
Cancer Research
|
June 28, 2018
Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients
Tord Hompland, Knut Håkon Hole, Harald Bull Ragnum, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 27, 2024
A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study
Joseph Marsilla, Jessica Weiss, Xiang Y Ye, et al.
Epigenetics
|
August 21, 2015
Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer
Malin Lando, Christina S Fjeldbo, Saskia M Wilting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2024
An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer
Jelena Lukovic, Melania Pintilie, Kathy Han, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 17, 2013
Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer
Harald Bull Ragnum, Kathrine Røe, Ruth Holm, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 10, 2018
Low dose-rate irradiation with [<sup>3</sup>H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft model
Stine Gyland Mikalsen, Lars Tore Gyland Mikalsen, Joe Alexander Sandvik, et al.
Molecular Oncology
|
January 22, 2022
miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer
Anja Nilsen, Tiril Hillestad, Vilde E Skingen, et al.
Page
of 7